Related Experiment Video
Updated: Nov 11, 2025

08:40
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
17.8K
Bi-direction effects between microbiome and MiRNAs in carcinogenesis.
Qinglin Wang1,2, Hanlin Ding1,2, Gaochao Dong1,2
1Department of Thoracic Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Baiziting 42, Nanjing, 210009, People's Republic of China.
Journal of Cancer Research and Clinical Oncology
|March 25, 2021
Summary
Microbiome dysbiosis is linked to diseases like cancer. MicroRNAs (miRNAs) mediate host-gut communication, offering potential for cancer diagnosis and treatment.
Area of Science:
- Microbiology
- Molecular Biology
- Oncology
Background:
- Gut microbiome dysbiosis is associated with immune-mediated diseases, obesity, diabetes, and cancer.
- The precise regulatory network governing host-gut microbiome communication remains incompletely defined.
- MicroRNAs (miRNAs) are increasingly recognized as key mediators in host-microbiome interactions.
Purpose of the Study:
- To summarize the bidirectional effects between miRNAs and the microbiome.
- To elucidate the role of miRNA-microbiome interactions in carcinogenesis.
- To highlight the potential of understanding this association for cancer treatment and diagnosis.
Main Methods:
- Literature review of studies on miRNA-microbiome interactions.
- Analysis of mechanisms regulating host-gut communication.
- Synthesis of evidence regarding miRNA involvement in cancer development.
Main Results:
- miRNAs play a crucial role in mediating communication between the host and the gut microbiome.
- Dysbiosis influences various diseases, including cancer, through metabolite and genetic regulation.
- The interplay between miRNAs and the microbiome significantly impacts carcinogenesis.
Conclusions:
- Understanding the miRNA-host-microbiome axis is vital for advancing cancer remission, diagnosis, and treatment.
- miRNA-microbiome interactions may serve as potential biomarkers for cancer.
- Further research into this bidirectional communication could lead to novel therapeutic strategies.
Related Concept Videos
MicroRNAs
3.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs
22.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.9K
The Tumor Microenvironment
7.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K
Mutagenicity and Carcinogenicity
1.6K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.6K
Mismatch Repair
5.7K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.7K
Mismatch Repair
42.5K
Overview
42.5K

